Every year roughly 5,000 people are diagnosed with Amyotrophic Lateral Sclerosis (ALS, which is why ALS in the Heartland ...

At more than 70 location from around the state of Nebraska, the 2025 Cornhusker State Games kicked-off on July 10. For the ...

US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...

The Model City hosted a large cornhole tournament on Sunday for a worthy cause. The first Paul Codispoti Memorial Cornhole ...

Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...

A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...

In a powerful act of compassion and community, Starr’s Mill High School organized an early graduation for rising senior ...

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

Brain-machine interfaces (BMIs) are becoming lifelines for people facing severe motor impairments. For many individuals with ...

In 2023, Chantler took it upon himself to look for a specialized mobility device called a 'TrailRider' to rent for an outdoor ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Detailed price information for Klotho Neurosciences Inc (KLTO-Q) from The Globe and Mail including charting and trades.